
Odaberite svoju etiketu
prikazano izravno na bočiciLaboratorijsko izvješće
PDF- Testirano
- CagriSema (Cagri+Sema) 10mg (5+5)
- Laboratorij
- Analiza Białek
- Datum
- October 2026
- Rezultat
- 99% purity (Cagrilintide 5.29 mg + Semaglutide 5.15 mg)
- Endotoksini
- 5.73 EU/vial
- Br. narudžbe
- Lozinka
Neovisno testirano, može se provjeriti lozinkom izravno u laboratoriju.
CagriSema (Cagri+Sema)
GLP-1
- Laboratorijski testirano · Čistoća 99%
- Šalje se iz Njemačke
Narudžba
- DHL s praćenjem
- Diskretno pakiranje
Na prvi pogled
CagriSema (Cagri+Sema) u brojkama
Ključni podaci iz našeg leksikona.
Cijeli članak u leksikonu- Class
- Amylin analog + GLP-1 agonist
- Use
- Subcutaneousweekly
- Sizes
- 5 to 20 mg3 sizes in the shop
What studies show
All 2 sources in the lexicon- 20.4 %NEJM, 2025
- Unternehmensmitteilung des Herstellers, 20.12.2024
Recenzije
Što kažu kupci
Samo stvarne narudžbe koje su uključivale CagriSema (Cagri+Sema).
Sve recenzijeZnanje
Sve o CagriSema (Cagri+Sema)
Detaljne informacije uskoro.
Doziranje
Učitavanje podataka o doziranju …
Dobro je imati
Što vam uz to treba
Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.
Inzulinske štrcaljke
10 kom. · 5.50 €
Alkoholne maramice
50 kom. · 10 €
Koliko vode?
Jedinice na štrcaljki za veličinu vaše bočice.
Otvori kalkulator →Is CagriSema approved?
No, the combination is not approved (as of 26 October 2026). Semaglutide alone has been approved since 2017, ChEMBL lists cagrilintide with phase 3 as the highest phase. ClinicalTrials.gov lists 18 phase 3 trials of the combination, 10 of them completed.
What does the combination add over the single compounds?
In REDEFINE 1 the combination came out ahead after 68 weeks. For all participants: -20.4 percent versus -14.9 (semaglutide alone), -11.5 (cagrilintide alone) and -3.0 (placebo). When taken as planned: -22.7 versus -16.1, -11.8 and -2.3 percent. The values of the single compounds come from the manufacturer's announcement, the abstract only reports combination and placebo.
Why two compounds in one vial?
Because they act on different receptors. Cagrilintide binds to amylin and calcitonin receptors, semaglutide to the GLP-1 receptor. In rats cagrilintide worked through specific nerve cells in the brainstem that semaglutide did not need. The effects on satiety and the stomach thus add up.
What do the trials show in type 2 diabetes?
In REDEFINE 2 weight fell by 13.7 percent after 68 weeks (placebo 3.4), 73.5 percent reached an HbA1c of 6.5 percent or below (placebo 15.9). In phase 2 HbA1c fell by 2.2 percentage points in 32 weeks. In REIMAGINE 2 the combination was slightly but significantly ahead of semaglutide alone on HbA1c.
How long do the compounds stay in the body?
In the first study of the combination the half-life of cagrilintide was 159 to 195 hours, that of semaglutide 145 to 165 hours, so both about one week. Cagrilintide did not change semaglutide blood levels. That is why the trials give the combination once a week.
Which side effects were seen?
Mainly gastrointestinal effects such as nausea, vomiting, diarrhoea or constipation: in REDEFINE 1 in 79.6 percent (placebo 39.9), in REDEFINE 2 in 72.5 percent (placebo 34.4). According to the trials they were mostly mild to moderate and passed.
How did the combination do directly against semaglutide?
In REDEFINE 5 in Japan and Taiwan weight fell by 18.4 percent with the combination after 68 weeks, by 11.9 percent with semaglutide alone. Gastrointestinal effects were similarly common in both groups (53 versus 51 percent).
Povezano
Srodni proizvodi
Tirzepatide
Peptidi · GLP-1 i gubitak masnoće GLP-1 i gubitak masnoće
10 veličine
Laboratorijski testirano
= od 10 €/bočica
Retatrutide
Peptidi · GLP-1 i gubitak masnoće GLP-1 i gubitak masnoće
11 veličine
Laboratorijski testirano
= od 16 €/bočica
Semaglutide
Peptidi · GLP-1 i gubitak masnoće GLP-1 i gubitak masnoće
6 veličine
Laboratorijski testirano
= od 10 €/bočica
Mazdutide
Peptidi · GLP-1 i gubitak masnoće GLP-1 i gubitak masnoće
2 veličine
= od 32 €/bočica
CagriSema (Cagri+Sema)